Perioperative management of patients with neurologic disease

Neurologic Clinics

Volumn 22, Issue 2, 2004, Pages 261-276

  Rubino, Frank A ^a,b,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; ACETYLCHOLINE; AMINOGLYCOSIDE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPIVACAINE; CARBAMAZEPINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; EDROPHONIUM; ESTER; IMMUNOGLOBULIN; LONG ACTING DRUG; MIVACURIUM; MORPHINE; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; PETHIDINE; PHENYTOIN; POTASSIUM; PROCAINAMIDE; PROPOFOL; PYRIDOSTIGMINE; SHORT ACTING DRUG; SUXAMETHONIUM; UNINDEXED DRUG;

AGE; AGITATION; AUTONOMIC DYSFUNCTION; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM DISEASE; COMORBIDITY; CONFUSION; CONSCIOUSNESS DISORDER; CONVALESCENCE; CORONARY ARTERY BYPASS GRAFT; CRITICAL ILLNESS; DELIRIUM; DEMENTIA; DIAPHORESIS; DISEASE COURSE; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SENSITIVITY; DRUG WITHDRAWAL; EATON LAMBERT SYNDROME; EPILEPTIC STATE; FAMILY; GERIATRIC PATIENT; HEAD INJURY; HEADACHE; HUMAN; HYPERTHERMIA; INTENSIVE CARE; IRRITABILITY; MEASUREMENT; MEDICAL PERSONNEL; MIGRAINE; MULTIPLE ORGAN FAILURE; MULTIPLE SCLEROSIS; MUSCLE RIGIDITY; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOCLONUS; MYOPATHY; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROMUSCULAR DISEASE; NEUROPATHY; PARKINSON DISEASE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PERIOPERATIVE PERIOD; PERIPHERAL NEUROPATHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE; SEPSIS; SEROTONIN SYNDROME; STEADY STATE; STRESS; STROKE; SURGICAL TECHNIQUE; TACHYCARDIA; TACHYPNEA; TREMOR; WITHDRAWAL SYNDROME;

EID: 1642314447     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2003.12.005     Document Type: Review

References (78)

1. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-67.
2. Birnbaum A, Hardie NA, Leppik IE, Conway JM, Bowers SE, Lackner T, et al. Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology 2003;60:555-9.
3. Lesser RP, Sundaram M. Treat the patient, not the test. Neurology 2003;60:534-5.
4. Pascuzzi RM. Myasthenia gravis and Lambert-Eaton syndrome. Ther Apher 2002;6:57-68.
5. Book WJ, Abel M, Eisenkraft JB. Anesthesia and neuromuscular diseases. Anesthesiol Clin North Am 1996;14:515-42.
6. Krucylak PE, Naunheim KS. Preoperative preparation and anesthetic management of patients with myasthenia gravis. Semin Thorac Cardiovasc Surg 1999;11:47-53.
7. Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mt Sinai J Med 2002;69:31-7.
8. Dunsire MF, Clarke SG, Stedmon JJ. Undiagnosed myasthenia gravis unmasked by neuromuscular blockade. Br J Anaesth 2001;86:727-30.
9. Kim JM, Mangold J. Sensitivity to both vecuronium and neostigmine in a sero-negative myasthenic patient. Br J Anaesth 1989;63:497-500.
10. Lumb AB, Calder I. 'Cured' myasthenia gravis and neuromuscular blockade. Anaesthesia 1989;44:828-30.
11. Ronager J, Ravnborg M, Vorstrup S. Clinical effect of high dose intravenous immunoglobulin compared to plasma exchange in patients with moderate to severe myasthenia gravis. Neurology 1999;52(6):S:184-5.
12. Seigne RD, Scott RP. Mivacurium chloride and myasthenia gravis. Br J Anaesth 1994;72:468-9.
13. O'Flaherty D, Pennant JH, Rao K, Giesecke AH. Total intravenous anesthesia with propofol for transsternal thymectomy in myasthenia gravis. J Clin Anesth 1992;4:241-4.
14. Akpolat N, Tilgen H, Gursoy F, Saydam S, Gurel A. Thoracic epidural anaesthesia and analgesia with bupivacaine for transsternal thymectomy for myasthenia gravis. Eur J Anaesthesiol 1997;14:220-3.
15. Nilsson E, Perttunen K, Kalso E. Intrathecal morphine for post-sternotomy pain in patients with myasthenia gravis: effects on respiratory function. Acta Anaesthesiol Scand 1997;41:549-56.
16. Howard JF Jr. Adverse drug effects on neuromuscular transmission. Semin Neurol 1990;10:89-102.
17. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-810.
18. Telford RJ, Hollway TE. The myasthenic syndrome: anaesthesia in a patient treated with 3.4 diaminopyridine. Br J Anaesth 1990;64:363-6.
19. Lundh H, Nilsson O, Rosen I, Johansson S. Practical aspects of 3, 4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome. Acta Neurol Scand 1993;88:136-40.
20. Inouye SK. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994;97:278-88.
21. Rummans TA, Evans JM, Krahn LE, Fleming KC. Delirium in elderly patients: evaluation and management. Mayo Clin Proc 1995;70:989-98.
22. Johnson JC. Delirium in the elderly. Emerg Med Clin North Am 1990;8:255-65.
23. Lipowski ZJ. Update on delirium. Psychiatr Clin North Am 1992;15:335-46.
24. Benbadis SR, Sila CA, Cristea RL. Mental status changes and stroke. J Gen Intern Med 1994;9:485-7.
25. Inouye SK. Letter to the editor. N Engl J Med 1999;341:370.
26. Holden U. Dementia in acute units: confusion. Nurs Stand 1995;9:37-9.
27. Marcantonio ER, Goldman L, Mangione CM, Ludwig LE, Muraca B, Haslauer CM, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994;271:134-9.
28. Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272:1518-22.
29. Wendel I. A case study of postoperative delirium. AORN J 2002;75:595-600.
30. Litaker D, Locala J, Franco K, Bronson DL, Tannous Z. Preoperative risk factors for postoperative delirium. Gen Hosp Psychiatry 2001;23:84-9.
31. Manos PJ, Wu R. The duration of delirium in medical and postoperative patients referred for psychiatric consultation. Ann Clin Psychiatry 1997;9:219-26.
32. Moller JT. Cerebral dysfunction after anaesthesia. Acta Anaesthesiol Scand Suppl 1997;110:13-6.
33. Parikh SS, Chung F. Postoperative delirium in the elderly. Anesth Analg 1995;80:1223-32.
34. Stolley JM, Hall GR, Collins J, Bleuer N, Adrian C, Buckwalter KC. Managing the care of patients with irreversible dementia during hospitalization for comorbidities. Nurs Clin North Am 1993;28:767-82.
35. Chrisman MB. The effects of dementia in the surgical patient. Plast Surg Nurs 2000;20:151-6.
36. Mion LC, Strumpf N. Use of physical restraints in the hospital setting: implications for the nurse. Geriatr Nurs 1994;15:127-32.
37. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke 1991;22:711-20.
38. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
39. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
40. Nadareishvili ZG, Rothwell PM, Beletsky V, Pagniello A, Norris JW. Long-term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis. Arch Neurol 2002;59:1162-6.
41. Barnett HJ. Efficacy of carotid endarterectomy translates to being efficacious with appropriate surgical skill. Arch Neurol 2002;59:1866-8.
42. Selnes OA, McKhann GM. Coronary-artery bypass surgery and the brain. N Engl J Med 2001;344:451-2.
43. McKhann GM, Grega MA, Borowicz LM Jr, Bechamps M, Selnes OA, Baumgartner WA, et al. Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction. Arch Neurol 2002;59:1422-8.
44. Bendszus M, Reents W, Franke D, Mullges W, Babin-Ebell J, Koltzenburg M, et al. Brain damage after coronary artery bypass grafting. Arch Neurol 2002;59:1090-5.
45. Wityk RJ, Restrepo L. Cardiac surgery and magnetic resonance imaging of the brain. Arch Neurol 2002;59:1074-6.
46. Mullges W, Berg D, Schmidtke A, Weinacker B, Toyka KV. Early natural course of transient encephalopathy after coronary artery bypass grafting. Crit Care Med 2000;28:1808-11.
47. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al. Longitudinal assessment of neurocognitive function after coronary- artery bypass surgery. N Engl J Med 2001;344:395-402.
48. Selnes OA, Royall RM, Grega MA, Borowicz LM Jr, Quaskey S, McKhann GM. Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Arch Neurol 2001;58:598-604.
49. Caplan LR. A 79-year-old musician with asymptomatic carotid artery disease. JAMA 1995;274:1383-9.
50. Wityk RJ, Goldsborough MA, Hillis A, Beauchamp N, Barker PB, Borowicz LM, et al. Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol 2001;58:571-6.
51. Van Dijk D, Jansen EW, Hijman R, Nierich AP, Diephuis JC, Moons KG, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA 2002;287:1405-12.
52. Mark DB, Newman MF. Protecting the brain in coronary artery bypass graft surgery. JAMA 2002;287:1448-50.
53. Rose EA. Off-pump coronary-artery bypass surgery. N Engl J Med 2003;348:379-80.
54. Nathoe HM, van Dijk D, Jansen EW, Suyker WJ, Diephuis JC, van Boven WJ, et al. A comparison of on-pump and off-pump coronary bypass surgery in low- risk patients. N Engl J Med 2003;348:394-402.
55. Llinas R, Barbut D, Caplan LR. Neurologic complications of cardiac surgery. Prog Cardiovasc Dis 2000;43:101-12.
56. Selnes OA, McKhann G. Late cognitive decline after CABG: inevitable or preventable? Neurology 2002;59:660-1.
57. Mullges W, Babin-Ebell J, Reents W, Toyka KV. Cognitive performance after coronary artery bypass grafting: a follow- up study. Neurology 2002;59:741-3.
58. Antunes PE, Anacleto G, de Oliveira JM, Eugenio L, Antunes MJ. Staged carotid and coronary surgery for concomitant carotid and coronary artery disease. Eur J Cardiothorac Surg 2002;21:181-6.
59. Fukuda I, Gomi S, Watanabe K, Seita J. Carotid and aortic screening for coronary artery bypass grafting. Ann Thorac Surg 2000;70:2034-9.
60. Di Tommaso L, Caputo M, Ascione R, Janelli G, De Amicis V, Spampinato N. Carotid endarterectomy and myocardial revascularization. A single stage procedure. Minerva Cardioangiol 1995;43:469-74.
61. D'Agostino RS, Svensson LG, Neumann DJ, Balkhy HH, Williamson WA, Shahian DM. Screening carotid ultrasonography and risk factors for stroke in coronary artery surgery patients. Ann Thorac Surg 1996;62:1714-23.
62. Chaturvedi S. The 10 most commonly asked questions about carotid endarterectomy. Neurologist 2002;8:203-5.
63. Rath PC, Agarwala MK, Dhar PK, Lakshmi C, Ahsan SA, Deb T, et al. Carotid artery involvement in patients of atherosclerotic coronary artery disease undergoing coronary artery bypass grafting. Indian Heart J 2001;53:761-5.
64. Hamulu A, Yagdi T, Atay Y, Buket S, Calkavur T, Iyem H. Coronary artery bypass and carotid endarterectomy: combined approach. Jpn Heart J 2001;42:539-52.
65. Lazar HL, Menzoian JO. Coronary artery bypass grafting in patients with cerebrovascular disease. Ann Thorac Surg 1998;66:968-74.
66. Fell RH. Migraine and surgery: avoidance of trigger mechanisms. Anaesthesia 1980;35:1006-7.
67. Silberstein SD, Welch KM. Painkiller headache. Neurology 2002;59:972-4.
68. Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001;41:629-37.
69. Poon SL, Lineaweaver WC, O'Keefe PJ, Alpert BS. Treatment of migraine headache in a postoperative microsurgical patient. Microsurgery 1990;11:282-4.
70. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford (England): Isis Medical Media; 1998.
71. Isler H. Headache drugs provoking chronic headache: historical aspects and common misunderstands. In: Diener HC, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag; 1988. p. 87-94.
72. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-4.
73. Kroll DA, Caplan RA, Posner K, Ward RJ, Cheney FW. Nerve injury associated with anesthesia. Anesthesiology 1990;73:202-7.
74. Warner MA. Perioperative neuropathies. Mayo Clin Proc 1998;73:567-74.
75. Norton JW. Gabapentin withdrawal syndrome. Clin Neuropharmacol 2001;24:245-6.
76. Buckley PF, Hutchinson M. Neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry 1995;58:271-3.
77. Gurrera RJ. Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia? Clin Neuropharmacol 2002;25:183-93.
78. Martin TG. Serotonin syndrome. Ann Emerg Med 1996;28:520-6.